NCT04060719View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 4, 2019

Primary Completion Date

October 17, 2019

Study Completion Date

October 17, 2019

Conditions
Healthy
Interventions
DRUG

BI 894416

tablet

DRUG

Rifampicin

tablet

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY